The Role of Formyl Peptide Receptor 1 Gene Polymorphisms in Human Colorectal Cancer. 2020

Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China.

Formyl peptide receptor 1 (FPR1) belongs to G protein-coupled receptors expressed mainly in phagocytic leukocytes. The gene encoding FPR1 is highly polymorphic and related to inflammation. In this study, we investigated the single nucleotide polymorphisms (SNPs) of Fpr1 in human colorectal cancer (CRC), and analyzed the association of Fpr1 SNPs with clinicopathological parameters and some specific diagnostic markers of CRC. Although the allele and genotype frequencies of Fpr1 SNPs in CRC tissues were not significantly different from that in whole blood cells derived from healthy Chinese subjects. Significant associations were observed between genotypes of c.289C>A and distant metastasis (P=0.001), and between genotypes of c.306T>C and tumor size (P=0.016). Genotypes of c.546C>A was closer to tumor size and lymphatic invasion (P=0.012 and P=0.043, respectively). Meanwhile, genotypes of c.1037C>A was related with tumor location and differentiation (P=0.000 and P=0.005, respectively). Besides, genotypes of c.576T>C>G was related with pathological type (P=0.000). Furthermore, several Fpr1 SNP positions including c.289 (C>A) and c.576 (G>C>T) were related to the expression of P53 (P=0.004 and P=0.008, respectively), and similar results were observed between other Fpr1 SNP positions and CEA, HER2 and Ki-67 (P<0.05). Our data demonstrate that Fpr1 SNPs may play the important role in the progression and metastasis of CRC.

UI MeSH Term Description Entries

Related Publications

Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
January 2012, PloS one,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
January 2011, PloS one,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
September 2007, Biochimica et biophysica acta,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
July 2016, BMC cancer,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
July 2017, Scientific reports,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
July 2007, European journal of immunology,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
May 2020, Cancers,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
October 2006, TheScientificWorldJournal,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
January 2021, Frontiers in pharmacology,
Shu-Qin Li, and Yang Yu, and Yan Zhang, and Yan-Ping Sun, and Xin-Xing Li, and Ning Su
March 1992, Biochemistry international,
Copied contents to your clipboard!